About salvarsan-luetic jaundice

Abstract

In the course of our work, we encounter luetic patients who developed jaundice after undergoing antiluetic treatment, including salvarsan therapy. The etiopathogenesis of this disease has not been fully clarified, and to this day it is the subject of heated debate among clinicians. The question remains unresolved: does jaundice in luetic patients arise from syphilis or from salvarsan.

Full Text

##article.viewOnOriginalSite##